HuGE Literature Finder
Records
1
-
2
The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients. Archives of medical science : AMS 2018 Oct 14 (6): 1416-1423. Belohlavkova Petra, Vrbacky Filip, Voglova Jaroslava, Racil Zdenek, Zackova Daniela, Hrochova Katerina, Malakova Jana, Mayer Jiri, Zak Pav |
A common novel splice variant of SLC22A1 (OCT1) is associated with impaired responses to imatinib in patients with chronic myeloid leukaemia. British journal of haematology 2013 Dec 163 (5): 631-9. Grinfeld Jacob, Gerrard Gareth, Alikian Mary, Alonso-Dominguez Juan, Ale Sakuntala, Valgañon Mikel, Nteliopoulos Georgios, White Deborah, Marin David, Hedgley Corinne, O'Brien Stephen, Clark Richard, Goldman John M, Milojkovic Dragana, Apperley Jane F, Foroni Letiz |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: